©The Author(s) 2022.
World J Gastroenterol. Dec 28, 2022; 28(48): 6950-6961
Published online Dec 28, 2022. doi: 10.3748/wjg.v28.i48.6950
Published online Dec 28, 2022. doi: 10.3748/wjg.v28.i48.6950
Table 5 Extra colonic malignancies in the colonic adenomatous polyposis of unknown etiology cohort
| Type of malignancy | Number | % | Incidence rate (Per 1000 person-years) |
| Non-melanoma skin cancer | 25 | 51 | 5.1 |
| Prostate | 6 | 12.2 | 1.2 |
| Melanoma | 5 | 10.2 | 1 |
| Breast | 4 | 8.2 | 0.8 |
| Lung | 2 | 4.1 | 0.4 |
| Uterine | 1 | 2 | 0.2 |
| Non-Hodgkin's Lymphoma | 1 | 2 | 0.2 |
| Gallbladder | 1 | 2 | 0.2 |
| Ovary | 1 | 2 | 0.2 |
| Bladder | 1 | 2 | 0.2 |
| Pancreas | 1 | 2 | 0.2 |
| Merkel cell tumor | 1 | 2 | 0.2 |
- Citation: Feldman D, Rodgers-Fouche L, Hicks S, Chung DC. Clinical features and long-term outcomes of patients with colonic oligopolyposis of unknown etiology. World J Gastroenterol 2022; 28(48): 6950-6961
- URL: https://www.wjgnet.com/1007-9327/full/v28/i48/6950.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i48.6950